Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin's lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to a new study.
http://www.nlm.nih.gov/medlineplus/news/fullstory_142086.html
http://www.nlm.nih.gov/medlineplus/news/fullstory_142086.html
No comments:
Post a Comment